Value Is Created Before the Process Begins: One of the most consistent findings in healthcare M&A is that the practices that achieve the highest valuations are those that invested meaningful time and resources in pre-sale preparation, often 18 to 36 months before formally entering a process. The moment you engage with potential buyers, the narrative is largely set. The financial statements are what they are; the operational profile is established; the payer contracts are in place. Buyers will underwrite what they observe. The highest-leverage moment to influence your valuation outcome is before the process begins, not during it.
Financial Hygiene: Clean Books, Clean Story
The first and most foundational step in pre-sale preparation is establishing clean, audit-ready financial statements. This means separating personal expenses from practice operations, normalizing owner compensation to fair market value, documenting all add-backs with supporting receipts and explanations, and ensuring that your chart of accounts clearly reflects the practice’s underlying economics.
Operational Efficiency as a Value Driver
Revenue cycle optimization is one of the most direct paths to EBITDA improvement, and therefore to higher valuation. Practices that reduce claims denial rates, accelerate collections, and eliminate coding errors can capture meaningful incremental revenue without adding clinical volume. Similarly, supply chain renegotiation, staffing ratio optimization, and overhead cost reduction can each add meaningful basis points to EBITDA margins. Practices represented by M&A advisors or investment banks achieved, on average, a 25% higher multiple from buyers, a premium largely attributable to pre-market optimization and competitive process management.
Leadership Structure and Succession Planning
Buyers evaluate practices not just as financial assets but as operating businesses that must continue to generate earnings after closing. A practice where all clinical leadership and patient relationships are concentrated in one or two founding physicians presents a concentration risk that buyers will discount. Building a second tier of physician leadership with younger partners who have long-term agreements, administrative responsibilities, and demonstrated patient loyalty is one of the most durable value creation strategies available to OB/GYN practice owners. This process takes time, which is why starting early matters.
Documenting Your Growth Story
Buyers pay for future earnings, not just historical performance. A practice that can articulate a credible, data-supported growth narrative, whether through geographic expansion, service line addition, provider recruitment, or payer contract improvement, will consistently achieve higher valuations than a comparable practice with no visible growth pathway. Work with your advisors to build a coherent growth model grounded in realistic assumptions and supported by documented market data. This narrative serves as the foundation of the Confidential Information Memorandum (CIM), which drives buyer interest and competitive tension in a formal sale process.